Durability of Response to Zoledronate Treatment and Competing Mortality in Paget's Disease of Bone
Author:
Affiliation:
1. Department of Medicine, Faculty of Medical and Health Science, University of Auckland and Bone Clinic, Endocrinology, Greenlane Clinical Centre; Auckland District Health Board; Auckland New Zealand
Publisher
Wiley
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.3029/fullpdf
Reference11 articles.
1. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone;Miller;Am J Med,1999
2. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease;Reid;N Engl J Med,2005
3. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years;Reid;J Bone Miner Res,2011
4. Paget's disease of bone in New Zealand: continued decline in disease severity;Cundy;Calcif Tissue Int,2004
5. Ralston SH; PRISM Trial Group. Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone;Langston;J Bone Miner Res,2010
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-term effectiveness of zoledronic acid in patients with Paget’s disease of bone – a retrospective cohort study;Endocrine;2024-03-30
2. Diagnosis and treatment of Paget’s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS);Journal of Endocrinological Investigation;2024-03-15
3. Osteocytes and Paget’s Disease of Bone;Current Osteoporosis Reports;2024-03-08
4. Paget’s Disease of Bone: Evaluation and Advances in Management;Endocrinology;2023-12-20
5. Targeting strategies for bone diseases: signaling pathways and clinical studies;Signal Transduction and Targeted Therapy;2023-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3